PSMA formulations and uses thereof

Details for Australian Patent Application No. 2004285543 (hide)

Owner PSMA Development Company, LLC

Inventors Schulke, Norbert; Maddon, Paul J.; Olson, William C.

Agent Davies Collison Cave

Pub. Number AU-A-2004285543

PCT Pub. Number WO2005/042029

Priority 10/695,667 27.10.03 US

Filing date 27 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/042029 Priority application(s): WO2005/042029

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285547-Once-a-day, oral, controlled-release, oxycodone dosage forms

2004285542-Device and method for monitoring body fluid and electrolyte disorders